Sections News

Dr Falk Pharma UK/Core Awards 2015

Friday, 17 October 2014 13:52

The Dr Falk Pharma UK/Core Awards 2015


The Dr Falk/Core awards recognise those who bring new knowledge and insight to the field of gastroenterology and hepatology. For those committed to furthering research or patient care, this year's awards are an opportunity to achieve national recognition as well as the financial support for career progression.

This year's prizes include:

  • A £1,000 essay prize for medical students on BSc or MRes courses
  • Four £1,500 bursaries for medical students taking full time science degrees
  • Two £2,500 bursaries to support research for F1/F2 doctors
  • A £1,000 award for primary and secondary care nurses for initiatives which have advanced patient care.

The application deadline is 5pm on Monday 16th March 2015. Applications received after this time will not be considered.

Please visit Core's website to download an application form.

National Nurse Endoscopist Course

Monday, 29 September 2014 09:02

This course is suitable for all aspiring non-medical / nurse endoscopists. It will be a practical and interactive course with constant support from experienced nurse endoscopists throughout the course duration. There is the option of gaining 30 academic credits with Kings College London (see attachment below).

Topics to be included (see below for learning objectives):

  • The principles and practice of GI Nursing
  • Anatomy & physiology of the GI tract
  • Pharmacology for endoscopy and safe sedation practice
  • Medico-legal issues and ethical implications including consent/ communication skills
  • Physical assessment, history taking and clinical examination
  • Indications for endoscopy, principals of pre assessment, patient selection, risk management, co morbidity issues and preparation for endoscopic procedures.
  • Technical skills of endoscopy and equipment / simulator training
    • OGD
    • Flexible Sigmoidoscopy
    • Colonoscopy
  • Pathophysiology and histopathology of the GI tract
  • Therapeutic endoscopy practice - biopsy and polypectomy
  • The Anus and Rectum master class
  • Emergency management and complications during GI endoscopy
  • Health promotion and management for the GI patient in Endoscopy
  • Professional issues and advanced practice
  • Role development, continuing education and career pathways for NE
  • Service development, evaluation and business planning
  • Relationships within the MDT
  • Links with JAG / JETS

Conditions of application

  • Applicants will need a supporting letter from both their Clinical Supervisor and their Line Manager detailing their suitability and availability for the course.
  • Ideal but not essential is that applicants should be in a trainee endoscopist role with dedicated training lists, at least one per week.
  • Registered on JETS – can be done on course
  • Recommend a senior nurse mentor, e.g. an advanced nurse practitioner or similar

Course Dates

This course consisting of the following 6 taught study days over a 5 month period with support from experienced nurse endoscopists throughout the course duration.

Tues 13th & Wed 14th January 2015
Wed 1st & Thurs 2nd April 2015
Tues 2nd & Wed 3rd June 2015

Course Fees

£1800 (+ £350 for optional academic accreditation)

Guidance on Decontamination of Equipment for Gastrointestinal Endoscopy: 2014 Edition

Thursday, 10 July 2014 13:58

The Report of a Working Party of the British Society of Gastroenterology Endoscopy Committee

June 2014

The 2008 guidance has been updated so as to incorporate the following developments:

  • The English Department of Health "Choice Frameworks for Local Policies and Procedures (CFPPs)" and equivalent documents from the devolved administrations.
  • Implications arising from moving decontamination facilities out of endoscopy units to centralised facilities, in some cases outside of the hospital campus; in particular the need to ensure a moist environment for endoscopes following last patient use and before decontamination, and conversely the maintenance of a dry storage state following decontamination and before next patient use.
  • Review of vCJD transmission risks, given that at the time of writing there are no known examples of vCJD arising as a result of endoscopy or surgery; guidance on decontamination of endoscopes following the performance of procedures in at-risk individuals is discussed, and quarantining of endoscopes is now deemed rarely necessary.
  • Some references to newer technologies such as NOTES and cholangioscopy.
  • A move away from enzymatic detergents, which have been linked to occupational dermatitis and asthma.
  • The introduction of audit tools, workforce recommendations and educational frameworks.

It is also acknowledged that there are many "stakeholders" in the field of decontamination. This, together with varying guidance from the devolved administrations, has frequently led to inconsistencies and misunderstandings. Against this background BSG Council has agreed that BSG will no longer co-ordinate revisions of its guidance, but a member of BSG Endoscopy will represent the Society on the Professional Expert Organisation Forum that has been established under the auspices of the Institute of Decontamination Sciences.

Finally Miles Allison would like to acknowledge the help and support of so many colleagues during his 12 years of involvement in this arena, in particular Tina Bradley, Helen Griffiths, Libby Thomson, Geoff Ridgway, Mike Bramble and the late Prof Don Jeffries.

18th ESGENA Conference

October 18-22, 2014
ACV, Vienna, Austria

Registration for the ESEGNA Conference is now open
Online registration and the programme can be found at the link below

Decontamination Alert - August 2013

Thursday, 22 August 2013 08:19

Choice Framework for local Policy and Procedures 01-06: Decontamination of flexible endoscopes details that manufacturer's instructions must be followed at all times when using an Endoscope Washer Disinfector (EWD), and selecting chemicals for use.

All units are asked to check that the chemicals (detergents and disinfectants) used in their EWDs are those tested by the machine manufacturer at the type-test stage with supporting evidence of efficacy. Under no circumstances should a chemical (i.e. disinfectant) be used that was not included in the type test data for that machine, this supports the need to follow manufacturer's instructions, as non-type tested chemicals may damage the internal mechanics of the EWD, therefore a possible risk to patients may occur.

If you are unsure which chemicals are recommended in your EWD please speak to your manufacturer requesting information specifically on 'type tested' chemicals.

Dr Helen Griffiths

Nurse Consultant Gastroenterology

Decontamination representative BSG Endoscopy Committee

On behalf of the Professional Expert Communications Forum: Decontamination of Medical Devices.

Page 1 of 3